Institut de Recerca Biomèdica de Lleida (IRBLleida)

Research facility


Location: Lleida, Spain (ES) ES

ISNI: 000000040425020X

ROR: https://ror.org/03mfyme49

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT (2025) Jonckheere S, Taminau J, Adams J, Haerinck J, De Coninck J, Verstappe J, De Clercq K, et al. Journal article A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens (2023) Almenara-Fuentes L, Rodriguez-Fernandez S, Rosell-Mases E, Kachler K, You A, Salvado M, Andreev D, et al. Journal article Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study (2023) Mark PB, Carrero JJ, Matsushita K, Sang Y, Ballew SH, Grams ME, Coresh J, et al. Journal article Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. (2023) Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar De Pinho N, et al. Journal article Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP (2023) Matsushita K, Kaptoge S, Hageman SHJ, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Journal article Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease (2021) Ortiz A, Ferro CJ, Balafa O, Burnier M, Ekart R, Halimi JM, Kreutz R, et al. Journal article Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets (2020) Matsushita K, Jassal SK, Sang Y, Ballew SH, Grams ME, Surapaneni A, Arnlov J, et al. Journal article